Cargando…
FASL rs763110 Polymorphism Contributes to Cancer Risk: An Updated Meta-Analysis Involving 43,295 Subjects
BACKGROUND: Published studies investigating the association between genetic polymorphism -884C/T (rs763110) of the FAS ligand (FASL) promoter and cancer risk reported inconclusive results. To derive a more precise estimation of the relationship, we performed an updated meta-analysis of all eligible...
Autores principales: | Xu, Lei, Zhou, Xin, Jiang, Feng, Qiu, Man-Tang, Zhang, Zhi, Yin, Rong, Xu, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781150/ https://www.ncbi.nlm.nih.gov/pubmed/24086353 http://dx.doi.org/10.1371/journal.pone.0074543 |
Ejemplares similares
-
Correction: FASL rs763110 Polymorphism Contributes to Cancer Risk: An Updated Meta-Analysis Involving 43,295 Subjects
por: Xu, Lei, et al.
Publicado: (2013) -
FasL (rs763110) gene polymorphism is not associated with susceptibility to rheumatoid arthritis in Croatian population
por: Artuković, Marinko, et al.
Publicado: (2020) -
Associations between FAS rs2234767 and FASL rs763110 polymorphisms and the risk of lung cancer: a meta-analysis of 39,736 subjects
por: Yu, Xiongjie, et al.
Publicado: (2016) -
Distinct role of the Fas rs1800682 and FasL rs763110 polymorphisms in determining the risk of breast cancer among Han Chinese females
por: Wang, Meng, et al.
Publicado: (2016) -
Hsa-miR-499 rs3746444 Polymorphism Contributes to Cancer Risk: A Meta-Analysis of 12 Studies
por: Qiu, Man-Tang, et al.
Publicado: (2012)